Clinical Outcomes Improvement Committee

Purpose:
The Clinical Outcomes Improvement Committee assists hematopoietic progenitor cell transplant programs with improving patient outcomes by providing resources, creating tools, and reviewing corrective action plans.

Current members of Clinical Outcomes Improvement Committee:

Position

Name

Organization

City

Country

Chair

Michael Lill MD

Blood and Marrow Transplant Program at the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center

Los Angeles

United States

Vice-Chair

C. Fred LeMaistre MD

Nashville

United States

Member

Luke Akard MD

Indiana Blood and Marrow Transplantation (IBMT)

Indianapolis

United States

Member

Ahmad Samer Al-Homsi MD

NYU Langone Health Hematopoietic Progenitor Cell Transplant Program

New York

United States

Member

Dr Dennis Gastineau MD

Mayo Clinic Rochester Blood and Marrow Transplant Program

Rochester

United States

Member

Kamar Godder MD, MPH

Nicklaus Children's Hospital Blood and Marrow Transplant Program

Miami

United States

Member
Chair, ASBMT Committee on Quality

Navneet Majhail

Cleveland Clinic Blood and Marrow Transplant Program

Cleveland

United States

Member

George Selby MD

The OU Medical Center Blood and Marrow Transplant Program

Oklahoma City

United States

Member

Amir Steinberg MD, FACP

Mount Sinai Bone Marrow and Stem Cell Transplantation Program

New York City

United States

Member

Phyllis Warkentin MD

Biologics Production Facility, Nebraska Medicine, The Nebraska Medical Center

Omaha

United States

Staff Liaison

Kara Wacker MBA, RAC

Foundation for the Accreditation of Cellular Therapy

Omaha

United States


Ask FACT

FAQ

As a Matter of FACT

FACT inspectors have free access to all FACT training and educational opportunities.